{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T01:09:24Z","timestamp":1780794564751,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.canlet.2008.12.016","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T10:19:40Z","timestamp":1233051580000},"page":"205-211","source":"Crossref","is-referenced-by-count":13,"title":["t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia"],"prefix":"10.1016","volume":"277","author":[{"given":"Francesca","family":"Micci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Panagopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Haugom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Kilen","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir E.","family":"Tj\u00f8nnfjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Beiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.12.016_bib1","series-title":"World Health Organization Classification of Tumors; Tumours of Heamatopoietic and Lynphoid Tissues \u2013 Pathology and Genetics","article-title":"Myelodysplastic\/myeloproliferative disease","author":"Vardiman","year":"2001"},{"key":"10.1016\/j.canlet.2008.12.016_bib2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0950-3536(87)80031-8","article-title":"Haematological classification of the chronic myeloid leukaemias","volume":"1","author":"Shepherd","year":"1987","journal-title":"Baillieres Clin. Haem."},{"key":"10.1016\/j.canlet.2008.12.016_bib3","unstructured":"F. Mitelman, B. Johansson, F. Mertens. Mitelman database of chromosome aberrations in cancer, <http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman>, 2008."},{"key":"10.1016\/j.canlet.2008.12.016_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2141.1996.396933.x","article-title":"Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome?","volume":"92","author":"Oscier","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2008.12.016_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3109\/10428190009059285","article-title":"Atypical chronic myeloid leukaemia with trisomy 21 mosaicism as a sole chromosomal abnormality","volume":"38","author":"Benedek","year":"2000","journal-title":"Leuk. Lymp."},{"key":"10.1016\/j.canlet.2008.12.016_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1008393002748","article-title":"Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia","volume":"11","author":"Hernandez","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2008.12.016_bib7","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood.V96.8.2862","article-title":"High incidence of biallelic point mutations in the Runt domain of the AML1\/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21","volume":"96","author":"Preudhomme","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.12.016_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cancergencyto.2003.10.002","article-title":"Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia","volume":"152","author":"Takeshita","year":"2004","journal-title":"Cancer Genet. Cytogen."},{"key":"10.1016\/j.canlet.2008.12.016_bib9","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","article-title":"The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2","volume":"65","author":"Reiter","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.12.016_bib10","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1038\/sj.onc.1208850","article-title":"The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene","volume":"24","author":"Bousquet","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.12.016_bib11","first-page":"369","article-title":"New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia","volume":"84","author":"Siena","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2008.12.016_bib12","first-page":"3592","article-title":"Fusion of H4\/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)","volume":"60","author":"Kulkarni","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.12.016_bib13","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1182\/blood.V97.12.3910","article-title":"H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)","volume":"97","author":"Schwaller","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.12.016_bib14","series-title":"Human Cytogenetics: Malignancy and Acquired Abnormalities","first-page":"57","article-title":"Cytogenetics in acute lymphoblastic leukemia","author":"Czepulkowski","year":"2001"},{"key":"10.1016\/j.canlet.2008.12.016_bib15","unstructured":"ISCN, An International System for Human Cytogenetic Nomenclature, in: L.G. Shaffer, N. Tommerup (Eds.), Karger S. Basel, 2005."},{"key":"10.1016\/j.canlet.2008.12.016_bib16","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.canlet.2008.12.016_bib17","series-title":"Human Cytogenetics \u2013 Malignancy and Acquired Abnormalities","first-page":"129","article-title":"Molecular Cytogenetic Technologies","author":"Kearny","year":"2001"},{"key":"10.1016\/j.canlet.2008.12.016_bib18","series-title":"Cancer Cytogenetics","article-title":"Acute Myeloid Leukemia","author":"Johansson","year":"2008"},{"key":"10.1016\/j.canlet.2008.12.016_bib19","series-title":"Cancer Cytogenetics","article-title":"Acute lymphoblastic leukemia","author":"Harrison","year":"2008"},{"key":"10.1016\/j.canlet.2008.12.016_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1098-2264(199607)16:3<155::AID-GCC1>3.0.CO;2-Y","article-title":"Primary vs. secondary neoplasia-associated chromosomal abnormalities\u2013balanced rearrangements vs. genomic imbalances?","volume":"16","author":"Johansson","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.canlet.2008.12.016_bib21","first-page":"2009","article-title":"The human RYK cDNA sequence predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain","volume":"8","author":"Tamagnone","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.12.016_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0968-0004(99)01537-6","article-title":"SAP-a putative DNA-binding motif involved in chromosomal organization","volume":"25","author":"Aravind","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2008.12.016_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0092-8674(00)81239-8","article-title":"A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice","volume":"85","author":"Fero","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2008.12.016_bib24","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1093\/emboj\/17.16.4657","article-title":"Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation","volume":"17","author":"Venkatachalam","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2008.12.016_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2008.12.016_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/carcin\/22.1.99","article-title":"Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (\u00b1) mouse tumors is carcinogen-and tissue-dependent","volume":"22","author":"French","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2008.12.016_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ng1361","article-title":"Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor PU.1","volume":"36","author":"Rosenbauer","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2008.12.016_bib28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood.V99.4.1364","article-title":"In vitro analyses of known and novel RUNX1\/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis","volume":"99","author":"Michaud","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.12.016_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2004.04966.x","article-title":"Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1\/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome","volume":"125","author":"Nakao","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2008.12.016_bib30","first-page":"101","article-title":"Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis","volume":"30","author":"Kobayashi","year":"1999","journal-title":"J. Med."},{"key":"10.1016\/j.canlet.2008.12.016_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.thj.6200143","article-title":"Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features","volume":"3","author":"Charrin","year":"2002","journal-title":"Hematol. J."},{"key":"10.1016\/j.canlet.2008.12.016_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2005.08.005","article-title":"Abnormalities of the long arm of chromosome 21 in 107 patients with hematopoietic disorders: a collaborative retrospective study of the Groupe Francais de Cytogenetique Hematologique","volume":"166","author":"Jeandidier","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.canlet.2008.12.016_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2141.2004.05038.x","article-title":"Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel","volume":"126","author":"Stark","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2008.12.016_bib34","first-page":"353","article-title":"Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses","volume":"71","author":"Nawata","year":"2000","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.canlet.2008.12.016_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(04)91001-9","article-title":"Imatinib as a paradigm of targeted therapies","volume":"91","author":"Druker","year":"2004","journal-title":"Adv. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508009439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508009439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:03:30Z","timestamp":1589511810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508009439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0304383508009439"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.12.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}